ORBIMED ADVISORS LLC 13D/13G Filings for NeuroPace, Inc. (NPCE)

ORBIMED ADVISORS LLC 13D and 13G filings for NeuroPace, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
6:30 pm
Sale
2024-09-3013GNeuroPace, Inc.
NPCE
ORBIMED ADVISORS LLC3,406,335
11.700%
-597,632decrease
(-14.93%)
Filing
2024-02-14
7:00 pm
Sale
2023-12-3113GNeuroPace, Inc.
NPCE
ORBIMED ADVISORS LLC4,003,967
15.200%
-8,314decrease
(-0.21%)
Filing
2023-02-14
4:48 pm
Unchanged
2022-12-3113GNeuroPace, Inc.
NPCE
ORBIMED ADVISORS LLC4,012,281
16.100%
0
(Unchanged)
Filing
2022-02-11
4:35 pm
Unchanged
2021-12-3113GNeuroPace, Inc.
NPCE
ORBIMED ADVISORS LLC4,012,281
16.500%
0
(Unchanged)
Filing
2021-04-29
5:17 pm
Purchase
2021-04-2613GNeuroPace, Inc.
NPCE
ORBIMED ADVISORS LLC4,012,281
16.800%
4,012,281increase
(New Position)
Filing